NCT00873015View on ClinicalTrials.gov

Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

August 31, 2012

Conditions
Subarachnoid Hemorrhage
Interventions
DRUG

Sodium nitrite

14 day continuous infusion of one of 3 escalating doses of sodium nitrite: 32 nmol/min/kg, 48 nmol/min/kg, or 64 nmol/min/kg

DRUG

Saline

14 day continuous infusion of a vehicle control infusion

Trial Locations (1)

22903

University of Virginia Health System Medical Center, Charlottesville

Sponsors
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Hope Pharmaceuticals

INDUSTRY